These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 28844901

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
    Jackson MJ, Kestur US, Hussain MA, Taylor LS.
    Mol Pharm; 2016 Jan 04; 13(1):223-31. PubMed ID: 26618718
    [Abstract] [Full Text] [Related]

  • 7. Combined Effects of Supersaturation Rates and Doses on the Kinetic-Solubility Profiles of Amorphous Solid Dispersions Based on Water-Insoluble Poly(2-hydroxyethyl methacrylate) Hydrogels.
    Schver GCRM, Lee PI.
    Mol Pharm; 2018 May 07; 15(5):2017-2026. PubMed ID: 29601723
    [Abstract] [Full Text] [Related]

  • 8. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers.
    Sun DD, Lee PI.
    J Control Release; 2015 Aug 10; 211():85-93. PubMed ID: 26054795
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Stability of indomethacin with relevance to the release from amorphous solid dispersions studied with ATR-FTIR spectroscopic imaging.
    Ewing AV, Clarke GS, Kazarian SG.
    Eur J Pharm Sci; 2014 Aug 18; 60():64-71. PubMed ID: 24832964
    [Abstract] [Full Text] [Related]

  • 11. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
    Sun DD, Ju TC, Lee PI.
    Eur J Pharm Biopharm; 2012 May 18; 81(1):149-58. PubMed ID: 22233548
    [Abstract] [Full Text] [Related]

  • 12. Formulation of Cinnarizine for Stabilization of Its Physiologically Generated Supersaturation.
    Maghsoodi M, Nokhodchi A, Oskuei MA, Heidari S.
    AAPS PharmSciTech; 2019 Mar 11; 20(3):139. PubMed ID: 30868302
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of crystal nucleation and growth by water-soluble polymers and its impact on the supersaturation profiles of amorphous drugs.
    Ozaki S, Kushida I, Yamashita T, Hasebe T, Shirai O, Kano K.
    J Pharm Sci; 2013 Jul 11; 102(7):2273-81. PubMed ID: 23658029
    [Abstract] [Full Text] [Related]

  • 14. Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.
    Xie T, Taylor LS.
    Mol Pharm; 2016 Mar 07; 13(3):873-84. PubMed ID: 26791934
    [Abstract] [Full Text] [Related]

  • 15. Evolution of supersaturation of amorphous pharmaceuticals: nonlinear rate of supersaturation generation regulated by matrix diffusion.
    Sun DD, Lee PI.
    Mol Pharm; 2015 Apr 06; 12(4):1203-15. PubMed ID: 25775257
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Wetting Kinetics: an Alternative Approach Towards Understanding the Enhanced Dissolution Rate for Amorphous Solid Dispersion of a Poorly Soluble Drug.
    Verma S, Rudraraju VS.
    AAPS PharmSciTech; 2015 Oct 06; 16(5):1079-90. PubMed ID: 25672820
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.